Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
356.00    1.00 (0.28%)
Bid:
351.00
Ask:
354.50
Spread: 3.50 (0.997%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Disposal

3 May 2016 10:53

RNS Number : 0299X
Caledonia Investments PLC
03 May 2016
 

 

 

 

Caledonia Investments plc

 

Sale of stake in Bowers & Wilkins

 

Caledonia Investments plc ("Caledonia") announces that it has sold its 20% stake in B&W Group Limited ("Bowers & Wilkins"), the designer, manufacturer and distributor of high-end audio equipment, for the sterling equivalent of £24m in cash, together with payment of an accrued dividend of £0.5m, as part of the wider sale of Bowers & Wilkins to EVA Automation Inc. ("EVA"), a US-based technology company.

 

Caledonia originally invested in Bowers & Wilkins in December 2011 and its exit at this time follows the majority owner's strategic decision to partner with EVA to leverage the Bowers & Wilkins brand through the broader market reach and technology platforms that EVA can offer. The investment has returned to Caledonia a money multiple of 1.2x and an IRR of 3.6%.

 

 

3 May 2016

For further information contact:

 

 

Caledonia Investments plc

+44 20 7802 8080

Will Wyatt,

Chief Executive

 

Stephen King,

Finance Director

 

Duncan Johnson,

Head of Unquoted Investments

Media contact:

Tulchan Communications

+44 20 7353 4200

Peter Hewer

 

END

 

Notes for editors:

 

Caledonia Investments plc

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately £1.6bn as at 31 March 2016. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 49 years.

 

In the unquoted arena, Caledonia seeks to invest £25m to £100m in private companies, either on a majority or minority basis, providing a meaningful presence and growth capital supporting double-digit operating margins. Its current unquoted portfolio includes Park Holidays (a UK caravan parks operator), Cobehold (a European unquoted investment house), The Sloane Club (a London residential club), Choice Care Group (a UK learning disability care homes provider), Seven Investment Management (a provider of discretionary fund management, retail investment funds and platform services to UK investors) and Gala Bingo (the UK market leading retail bingo operator).

 

For additional information on Caledonia, please visit www.caledonia.com.

 

Bowers & Wilkins

Bowers & Wilkins, founded in 1966 by John Bowers, is a leading manufacturer and distributor of premium audio equipment throughout the world. It manufactures a wide range of products including the iconic Zeppelin docking station and the premium 800 diamond speakers used at Abbey Road studios.

 

Further information on Bowers & Wilkins and its products can be found at www.bowers-wilkins.co.uk.

 

 

Neither the contents of Caledonia's nor Bowers & Wilkins' websites, nor the contents of any website accessible from hyperlinks on these websites (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISKXLBBQEFEBBL
Date   Source Headline
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)
22nd Nov 20227:00 amRNSDirectorate Change
22nd Nov 20227:00 amRNSHalf-year Report
7th Nov 202210:49 amRNSNet Asset Value(s)
7th Oct 20227:00 amRNSUnaudited net asset value and portfolio update
30th Sep 20224:21 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:51 pmRNSDirector/PDMR Shareholding
6th Sep 202210:17 amRNSNet Asset Value(s)
23rd Aug 20225:21 pmRNSDirector/PDMR Shareholding
15th Aug 20222:21 pmRNSDirector Declaration
4th Aug 202212:41 pmRNSNet Asset Value(s)
27th Jul 20224:47 pmRNSResult of AGM
19th Jul 20224:59 pmRNSDirector Declaration
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding
14th Jun 20221:51 pmRNSDirector/PDMR Shareholding
8th Jun 20229:36 amRNSNet Asset Value(s)
6th Jun 20223:33 pmRNSDirector/PDMR Shareholding
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.